[HTML][HTML] Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers
D Di Lisi, CC Dessalvi, C Zito, C Madaudo… - Current Problems in …, 2023 - Elsevier
In recent years, important advances have been made in the field of Cardio-Oncology. The
2022 ESC Guidelines on Cardio-Oncology proposed a baseline cardiovascular risk …
2022 ESC Guidelines on Cardio-Oncology proposed a baseline cardiovascular risk …
Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management
C Jiang, H Xu, Y Wu - Life Sciences, 2023 - Elsevier
Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in
cancer survivors. The development of coronary ischemia events, myocardial infarction, and …
cancer survivors. The development of coronary ischemia events, myocardial infarction, and …
Patients with metastatic cancer have worse short-term coronary artery bypass grafting outcomes: A population-based study of National Inpatient Sample from 2015 to …
R Li, Q Luo, SJ Huddleston - Cardiovascular Revascularization Medicine, 2024 - Elsevier
Background Metastasis is a hallmark for cancer progression. While patients with metastatic
cancer (MC) have higher risk profiles, outcomes of coronary artery bypass grafting (CABG) …
cancer (MC) have higher risk profiles, outcomes of coronary artery bypass grafting (CABG) …
[PDF][PDF] Intervenciones Cardíacas Invasivas en Pacientes con Cáncer Avanzado: Evaluación de Bene< icios y Riesgos
N Espinola-Zavaleta, P Martinez-Dominguez… - researchgate.net
Las neoplasias malignas avanzadas representan un riesgo competitivo signipicativo de
mortalidad y la evidencia para evaluar el riesgo-benepicio de las intervenciones cardı́acas …
mortalidad y la evidencia para evaluar el riesgo-benepicio de las intervenciones cardı́acas …